NEULANDLAB Aperçu des actions
Neuland Laboratories Limited fabrique et vend des ingrédients pharmaceutiques actifs (IPA) en Inde, en Europe, aux États-Unis et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 5/6 |
| Performances passées | 4/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
Neuland Laboratories Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | ₹16,068.90 |
| Plus haut sur 52 semaines | ₹16,560.75 |
| Plus bas sur 52 semaines | ₹4,926.05 |
| Bêta | 0.98 |
| 1Variation sur 1 mois | 15.18% |
| Variation sur 3 mois | 29.54% |
| Variation sur 1 an | 210.71% |
| 3Variation sur 3 ans | 813.32% |
| Variation sur 5 ans | 3,519.94% |
| Évolution depuis l'introduction en bourse | 16,814.63% |
Nouvelles et mises à jour récentes
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14
Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Recent updates
Concerns Surrounding Neuland Laboratories' (NSE:NEULANDLAB) Performance
Nov 14Neuland Laboratories Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Nov 09Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Is Well Worth Watching
Nov 08After Leaping 27% Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Are Not Flying Under The Radar
Oct 17Neuland Laboratories Limited's (NSE:NEULANDLAB) Shares Climb 44% But Its Business Is Yet to Catch Up
Aug 22Is Now The Time To Put Neuland Laboratories (NSE:NEULANDLAB) On Your Watchlist?
Aug 02Neuland Laboratories' (NSE:NEULANDLAB) Dividend Will Be Increased To ₹14.00
Jul 12Optimistic Investors Push Neuland Laboratories Limited (NSE:NEULANDLAB) Shares Up 28% But Growth Is Lacking
Jul 02Neuland Laboratories' (NSE:NEULANDLAB) Upcoming Dividend Will Be Larger Than Last Year's
Jun 19Is Neuland Laboratories (NSE:NEULANDLAB) Using Too Much Debt?
Jun 12Neuland Laboratories (NSE:NEULANDLAB) Will Pay A Larger Dividend Than Last Year At ₹14.00
May 21There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Rendement pour les actionnaires
| NEULANDLAB | IN Pharmaceuticals | IN Marché | |
|---|---|---|---|
| 7D | 7.9% | 1.1% | 2.0% |
| 1Y | 210.7% | 43.3% | 28.6% |
Rendement vs Industrie: NEULANDLAB a dépassé le secteur Indian Pharmaceuticals qui a rapporté 43.3 % au cours de l'année écoulée.
Rendement vs marché: NEULANDLAB a dépassé le marché Indian qui a rapporté 28.6 % au cours de l'année écoulée.
Volatilité des prix
| NEULANDLAB volatility | |
|---|---|
| NEULANDLAB Average Weekly Movement | 9.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Cours de l'action stable: Le cours de l'action de NEULANDLAB a été volatil au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de NEULANDLAB ( 9% ) est restée stable au cours de l'année écoulée, mais reste supérieure à 75 % des actions de Indian.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1984 | 1,643 | Davuluri Rao | www.neulandlabs.com |
Neuland Laboratories Limited fabrique et vend des ingrédients pharmaceutiques actifs (IPA) en Inde, en Europe, aux États-Unis et dans le monde entier. Elle propose également des solutions de fabrication à façon, ainsi que des services de synthèse de peptides. Neuland Laboratories Limited a été créée en 1984 et son siège social se trouve à Hyderabad, en Inde.
Neuland Laboratories Limited Résumé des fondamentaux
| NEULANDLAB statistiques fondamentales | |
|---|---|
| Capitalisation boursière | ₹206.36b |
| Bénéfices(TTM) | ₹2.80b |
| Recettes(TTM) | ₹15.28b |
73.8x
Ratio P/E13.5x
Ratio P/SLe site NEULANDLAB est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| NEULANDLAB compte de résultat (TTM) | |
|---|---|
| Recettes | ₹15.28b |
| Coût des recettes | ₹7.31b |
| Marge brute | ₹7.97b |
| Autres dépenses | ₹5.17b |
| Les revenus | ₹2.80b |
Derniers bénéfices déclarés
Sep 30, 2024
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 217.98 |
| Marge brute | 52.14% |
| Marge bénéficiaire nette | 18.30% |
| Ratio dettes/capitaux propres | 6.7% |
Quelles ont été les performances à long terme de NEULANDLAB?
Voir les performances historiques et les comparaisons